The selective inhibition of the catalytic activity of the PI3K/AKR mouse strain thymoma (AKT) pathway may decrease the incidence of resistance to MEK inhibitors in metastatic uveal melanoma (Frey et al., 2020). This evidence concerns the gene AKT1 and uveal melanoma.